About N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide
N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide (PubChem CID 50991028) has the molecular formula C31H31F2N5O5S
and a molecular weight of 623.68 g/mol. Its IUPAC name is N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide.
Molecular Properties
| Compound Name | N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide |
| PubChem CID | 50991028 |
| Molecular Formula | C31H31F2N5O5S |
| Molecular Weight | 623.68 g/mol |
| Exact Mass | 623.20 |
| IUPAC Name | N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide |
| SMILES | CCCCc1nc(C)n(-c2ncc(OC(F)F)cn2)c(=O)c1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)C2CC2)cc1 |
| InChI | InChI=1S/C31H31F2N5O5S/c1-3-4-8-26-25(29(40)38(19(2)36-26)31-34-17-23(18-35-31)43-30(32)33)16-20-10-12-21(13-11-20)24-7-5-6-9-27(24)44(41,42)37-28(39)22-14-15-22/h5-7,9-13,17-18,22,30H,3-4,8,14-16H2,1-2H3,(H,37,39) |
| InChIKey | SPSVJPLXWHIVRQ-UHFFFAOYSA-N |
| XLogP | 4.75 |
| TPSA | 133.14 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 623.68 |
| LogP ≤ 5 | 4.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Analyze N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide?
The IUPAC name of N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide (CID 50991028) is N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide.
What is the SMILES notation for N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide?
The canonical SMILES for N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide is CCCCc1nc(C)n(-c2ncc(OC(F)F)cn2)c(=O)c1Cc1ccc(-c2ccccc2S(=O)(=O)NC(=O)C2CC2)cc1.
What is the InChIKey of N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide?
The InChIKey is SPSVJPLXWHIVRQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H31F2N5O5S/c1-3-4-8-26-25(29(40)38(19(2)36-26)31-34-17-23(18-35-31)43-30(32)33)16-20-10-12-21(13-11-20)24-7-5-6-9-27(24)44(41,42)37-28(39)22-14-15-22/h5-7,9-13,17-18,22,30H,3-4,8,14-16H2,1-2H3,(H,37,39).
What are the key properties of N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide?
N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide has a molecular weight of 623.68 g/mol, XLogP of 4.75, 12 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[[4-butyl-1-[5-(difluoromethoxy)pyrimidin-2-yl]-2-methyl-6-oxopyrimidin-5-yl]methyl]phenyl]phenyl]sulfonylcyclopropanecarboxamide is sourced from PubChem (CID 50991028), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).